Search

everythinglearnresearchcommunity

for

Search:↓

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Wnt7a protein is crucial for development and tissue maintenance and plays varying roles in diseases and potential treatments.

Higher DHT in male baldness may protect against prostate cancer.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Keratin 18 helps diagnose and predict cancer progression and affects cancer growth and spread.

Heavy metals like arsenic, cadmium, and lead can increase cancer risk and worsen outcomes.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Cheonggukjang may help prevent and manage various diseases and improve overall health, but its odor and safety concerns need addressing.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

The book details skin conditions in older adults, their link to mental health, cancer treatment importance, hair loss remedies, and managing autoimmune and itchy skin.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Oral contraceptives provide various health benefits beyond birth control, including managing menstrual issues, skin conditions, pain, and reducing the risk of certain cancers.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.